ArticleBlood advances2021

Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent-based analysis.

Hyehyun Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.